A Phase 2/3 Study To Assess The Efficacy And Safety Of Dupilumab Versus Placebo In Adults And Adolescents With Eosinophilic Gastritis With Or Without Eosinophilic Duodenitis

Evan S. Dellon(University of North Carolina at Chapel Hill), Arsalan Shabbir(Northwestern University), Jennifer Maloney(Regeneron (United States)), Renata Martincova(Icahn School of Medicine at Mount Sinai), Eric Mortensen(Regeneron (United States)), Lila Glotfelty(Icahn School of Medicine at Mount Sinai), Heather Paleczny(Regeneron (United States)), Marc E. Rothenberg(Cincinnati Children's Hospital Medical Center), Mirna Chehade(New York Proton Center), Elizabeth Laws(Sanofi (United States))

Journal of Allergy and Clinical Immunology

February 1, 2024

Cited by 1

|Journal of Allergy and Clinical Immunology|2011|2.1k

|Gastroenterology|2012|2k

|Gastroenterology|2018|1.7k

|Gastroenterology|2018|1.1k

|Gastroenterology|2015|996

Related Papers